oxymatrine has been researched along with D-fructopyranose in 3 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (D-fructopyranose) | Trials (D-fructopyranose) | Recent Studies (post-2010) (D-fructopyranose) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 18,095 | 1,041 | 5,633 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, SM; Molero, JC; Xu, J; Xue, CL; Ye, JM; Zeng, XY; Zhou, X | 1 |
| Hu, ZJ; Shi, L; Shi, LJ; Song, GY; Wang, C; Zhang, DH; Zhang, HF | 1 |
| Chen, S; Fei, W; Hu, Z; Huang, X; Liu, X; Ren, L; Yu, X; Zhang, H; Zhen, Y | 1 |
3 other study(ies) available for oxymatrine and D-fructopyranose
| Article | Year |
|---|---|
Screening for the efficacy on lipid accumulation in 3T3-L1 cells is an effective tool for the identification of new anti-diabetic compounds.
Topics: 3T3-L1 Cells; Adiposity; Alkaloids; Animals; Anti-Obesity Agents; Bridged-Ring Compounds; Cell Line; Dietary Fats; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Fatty Liver; Fructose; Glucose Intolerance; High-Throughput Screening Assays; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Quinolizines; Triglycerides | 2012 |
Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated recep
Topics: Alkaloids; Animals; Body Weight; Diet; Dose-Response Relationship, Drug; Dyslipidemias; Energy Intake; Fatty Acids; Fatty Liver; Fructose; Gene Expression Regulation; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; PPAR alpha; Quinolizines; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Sterol Regulatory Element Binding Protein 1 | 2013 |
Oxymatrine relieves high-fructose/fat-induced obesity via reprogramming the activity of lipid metabolism-related enhancer.
Topics: Animals; Fructose; Lipid Metabolism; Non-alcoholic Fatty Liver Disease; Obesity; Proto-Oncogene Proteins c-bcl-2; Rats | 2023 |